Live Earnings Conference Call: eXoZymes will host a live Q3 2026 earnings call on November 19, 2026 at 5:00PM ET. Follow this link to get details and listen to eXoZymes' Q3 2026 earnings call when it goes live. Get details. NASDAQ:EXOZ eXoZymes Q3 2026 Earnings Date & Estimates $3.54 +0.12 (+3.35%) As of 11:19 AM Eastern This is a fair market value price provided by Massive. Learn more. eXoZymes is estimated to report Q3 2026 earnings on Thursday, November 19, 2026. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 19, 2026Conference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) Live Call not available Upcoming EventEarnings Conference CalleXoZymes Q3 202600:00 / 00:00Live Transcript Follow Audio eXoZymes Q3 2026 Earnings PreviewAnalyst estimates for eXoZymes' Q3 2026 results have not been published yet. MarketBeat will post consensus EPS and revenue estimates here as they become available. In the same quarter a year earlier eXoZymes reported -$0.27 per share.Recent Track RecordLast ReportedQ3 2026Last Quarter EPS-$0.24Prepare for the Q3 2026 CallQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Q3 2026 Earnings ReportQ2 2026 Earnings ReportQ1 2026 Earnings Report Earnings DocumentsQuarterly report(10-Q) eXoZymes Q3 2026 Earnings FAQ When does eXoZymes report Q3 2026 earnings? eXoZymes (NASDAQ:EXOZ) is estimated to report Q3 2026 earnings on Thursday, November 19, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What time is eXoZymes' Q3 2026 earnings call? eXoZymes' Q3 2026 earnings conference call is scheduled for Thursday, November 19, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. eXoZymes Earnings HeadlinesReviewing eXoZymes (NASDAQ:EXOZ) and Upstream Bio (NASDAQ:UPB)November 16 at 2:15 AM | americanbankingnews.comeXoZymes Highlights Investor Presentation for Capital Markets OutreachOctober 9, 2026 | tipranks.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 19 at 1:00 AM | Base Camp Trading (Ad)eXoZymes Completes New Securities Offering to Fund PipelineJuly 1, 2026 | tipranks.comeXoZymes Secures NIH Grant to Advance Cannabinoid PipelineJune 26, 2026 | tipranks.comeXoZymes Completes Nasdaq Equity Offering to Fund PipelineJune 17, 2026 | tipranks.comSee More eXoZymes Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like eXoZymes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on eXoZymes and other key companies, straight to your email. Email Address About eXoZymeseXoZymes (NASDAQ:EXOZ) is a biotechnology company focused on cell-free biomanufacturing. Its approach uses enzymes outside living cells to produce compounds, offering an alternative to conventional manufacturing methods. The company’s work centers on developing its biomanufacturing platform and applying it to the production of useful molecules. Publicly available information about specific commercial products, customer markets, geographic reach and company leadership is limited.View eXoZymes ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Lowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes ShapeGeneral Motors Faces a Cost Squeeze as Factory Automation Takes Center StageNVIDIA's Earnings Were Strong, But Can the Next CEO Keep the Momentum Going? Upcoming Earnings Agilent Technologies (11/23/2026)Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.